Darcy Frear

DARCY FREAR, PhD ’19, speech and hearing bioscience and technology, is a director of global regulatory policy at BridgeBio, a biotechnology company dedicated to developing therapies for patients with rare genetic diseases. In this role, Frear leads cross-industry collaborations with the US Food and Drug Administration and biopharmaceutical partners to advance innovative, patient-centered approaches to rare disease drug development. Before joining BridgeBio, Frear held roles in regulatory program management and policy at BioMarin and Genentech, building on her early career in health care management consulting. Beyond her professional work, Darcy is an active leader and mentor in the Washington, DC, dragon boat community, continuing her long-standing passion for the sport as a former coach of the Harvard Dragon Boat team. She earned a BS in biomedical engineering from Arizona State University.